Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $56000.0.

  • International Stem Cell's Depreciation & Amortization (CF) rose 566.04% to $56000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $219000.0, marking a year-over-year increase of 950.0%. This contributed to the annual value of $206000.0 for FY2024, which is 618.56% up from last year.
  • Per International Stem Cell's latest filing, its Depreciation & Amortization (CF) stood at $56000.0 for Q3 2025, which was up 566.04% from $54000.0 recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Depreciation & Amortization (CF) peaked at $67000.0 during Q4 2021, and registered a low of $47000.0 during Q3 2023.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $54000.0 (2024), whereas its average is $55000.0.
  • As far as peak fluctuations go, International Stem Cell's Depreciation & Amortization (CF) plummeted by 2238.81% in 2022, and later skyrocketed by 1276.6% in 2024.
  • Quarter analysis of 5 years shows International Stem Cell's Depreciation & Amortization (CF) stood at $67000.0 in 2021, then dropped by 22.39% to $52000.0 in 2022, then fell by 7.69% to $48000.0 in 2023, then rose by 12.5% to $54000.0 in 2024, then increased by 3.7% to $56000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $56000.0 in Q3 2025, compared to $54000.0 in Q2 2025 and $55000.0 in Q1 2025.